As of 2026-09-29, the EV/EBITDA ratio of AVITA Medical Inc (RCEL) is -11.11. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AVITA's latest enterprise value is 405.96 mil USD. AVITA's TTM EBITDA according to its financial statements is -36.55 mil USD. Dividing these 2 quantities gives us the above AVITA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 15.3x - 16.1x | 15.5x |
| Forward P/E multiples | 18.5x - 21.9x | 19.2x |
| Fair Price | (23.17) - (20.30) | (21.83) |
| Upside | -293.7% - -269.7% | -282.5% |
| Date | EV/EBITDA |
| 2026-09-25 | -11.01 |
| 2026-09-24 | -10.79 |
| 2026-09-23 | -10.26 |
| 2026-09-22 | -10.71 |
| 2026-09-21 | -10.16 |
| 2026-09-18 | -10.32 |
| 2026-09-17 | -10.48 |
| 2026-09-16 | -9.84 |
| 2026-09-15 | -9.63 |
| 2026-09-14 | -9.62 |
| 2026-09-11 | -9.36 |
| 2026-09-10 | -9.34 |
| 2026-09-09 | -9.59 |
| 2026-09-08 | -9.80 |
| 2026-09-04 | -10.47 |
| 2026-09-03 | -10.25 |
| 2026-09-02 | -10.10 |
| 2026-09-01 | -9.52 |
| 2026-08-31 | -9.54 |
| 2026-08-28 | -9.75 |
| 2026-08-27 | -9.73 |
| 2026-08-26 | -9.95 |
| 2026-08-25 | -9.88 |
| 2026-08-24 | -9.38 |
| 2026-08-21 | -9.51 |
| 2026-08-20 | -9.53 |
| 2026-08-19 | -9.74 |
| 2026-08-18 | -9.33 |
| 2026-08-17 | -7.69 |
| 2026-08-14 | -7.65 |
| 2026-08-13 | -7.78 |
| 2026-08-12 | -7.87 |
| 2026-08-11 | -7.94 |
| 2026-08-10 | -7.44 |
| 2026-08-07 | -7.58 |
| 2026-08-06 | -5.04 |
| 2026-08-05 | -4.80 |
| 2026-08-04 | -4.93 |
| 2026-08-03 | -4.93 |
| 2026-07-31 | -4.74 |
| 2026-07-30 | -4.82 |
| 2026-07-29 | -4.77 |
| 2026-07-28 | -4.92 |
| 2026-07-27 | -5.04 |
| 2026-07-24 | -4.92 |
| 2026-07-23 | -4.92 |
| 2026-07-22 | -5.20 |
| 2026-07-21 | -5.32 |
| 2026-07-20 | -5.36 |
| 2026-07-17 | -5.33 |